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Background: Prevalence of non-communicable diseases are a challenging problems among menopausal women
specially in a least developed country like Bangladesh, where majority of women suffering from at least one chronic
diseases after menopausal age. So, the main objective of this study was to determine the prevalence of metabolic
syndrome and related risk factors in Bangladeshi pre- and post-menopausal women living in the rural setting.
Methods: This study is based on a community based cross-sectional survey among 1802 rural women aged
≥15 years. Metabolic syndrome was defined according to the criteria of NCEP-ATP III. Logistic regression was used
to estimate the association between menopausal status and metabolic syndrome and its components.
Results: Metabolic syndrome was presented in 25.6% respondents and it was more prevalent among
post-menopausal (39.3%) as compared to pre-menopausal (16.8%) women. Logistic regression analysis reveals that
prevalence of metabolic syndrome was 1.78 times higher in post-menopausal women than pre-menopausal
women (P = 0.001). Prevalence of high blood pressure, elevated fasting blood glucose, and high triglyceride were
significantly higher in post-menopausal women than pre-menopausal women (P < 0.05). However, prevalence of
low high-density lipoprotein cholesterol was significantly lower in post-menopausal women than pre-menopausal
women (P < 0.001).
Conclusions: Metabolic syndrome seems to be a major health problem among post-menopausal women in many
developing countries like Bangladesh and proper policy emphasis should be given on its prevention and control.
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The prevalence of chronic non-communicable diseases
such as cardiovascular diseases and type 2 diabetes is in-
creasing significantly in Bangladesh [1]. This increase is
observed not only in the urban areas but also in the
rural population, especially rural women in Bangladesh
seems to be more vulnerable who are mostly poor and
physically active [2]. The metabolic syndrome (MS) is a* Correspondence: jsubrina@hdrcrp.org
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reproduction in any medium, provided the orcluster of risk factors including obesity, glucose intoler-
ance, dyslipidemia, and hypertension that increase the
risk for cardiovascular disease and type 2 diabetes [3,4].
A striking increase in the number of people with the MS
has taken place worldwide not only in developed coun-
tries but also in developing countries considerably due
to changing environment and lifestyle [5].
Previous studies have showed that MS and cardiovas-
cular diseases are more common in women above 55
years of age with significant increase in individual risk
factors in the postmenopausal phase [6,7]. Changing
hormonal milieu with decreasing estrogen and alteration
of its ratio with testosterone has been implicated as a
causal factor for the emergence of MS at menopausalLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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aging also play roles to clustering of cardio-metabolic
risk factors [10]. Questions remain whether menopause
has a causative contribution to the deteriorating meta-
bolic profile that is independent of chronological aging.
Prevalence of MS among pre- and post-menopausal
women has varied according to different population. To
date, several previous studies found a significance dif-
ference in prevalence of MS among pre- and post-
menopausal women [11-17]. However, studies related to
MS and menopausal status is limited in South Asia [14].
South Asian women, in general are prone to have MS at
a younger age and have severe morbidity and mortality
consequences as compared to Caucasians and other
Asians [18,19]. Several studies found that menopausal
status is influentially linked to some features of MS
[11,14,16]. However, data on the empirical study of MS
in Bangladesh are very rare. So far no studies have been
conducted in Bangladesh to determine the prevalence of
MS among pre- and post- menopausal women who are
mostly poor and have limited or no access to health care
services. In our previous studies we found that preva-
lence of metabolic syndrome was nearly 31% among
rural women in Bangladesh, more than 85% rural wo-
men have low HDL cholesterol and nearly 31% have
high fasting blood glucose [20,21]. Thus, it becomes ne-
cessary to measure prevalence of MS in Bangladeshi
rural women focusing menopausal status for taking an
early lifestyle interventions and treatment to prevent
many non-communicable diseases in rural population as
they are now confronting with an emerging health epi-
demic of MS. Thus, the objective of this study is to esti-
mate the prevalence of MS in Bangladeshi rural women
considering their menopausal status and further exam-
ined the association between menopausal status and MS
and its components.
Methods
Study procedure and subjects
In a community based cross-sectional study of rural
women, a total of 1802 participants aged ≥15 years were
selected using stratified multistage random sampling.
This sample size was sufficient to test all the research
hypotheses at the 5% level of significance with a power
of 80% (β = 0.20). Subjects were excluded having chronic
illness such as hypothyroidism, pregnant women, those
on hormone replacement therapy (HRT) as well as wo-
men with known illness such as ischaemic heart disease
(IHD), diabetes and hypertension. The study uses the
World Health Organization’s STEPS approach (modified)
which entails stepwise collection of the risk factor data
based on standardized questionnaires covering demogra-
phic characteristics, somatic illnesses, somatic and mental
symptoms, medications, life style, and health-relatedbehavior (step 1), basic physical measures (step 2) and
basic biochemical investigations such as blood glucose
and cholesterol (step 3). Women were defined as post-
menopausal if they had reported their last menses to be at
least 12 months previously; pre-menopausal if they had an
unchanged and regular menstrual pattern during the last
five years, without typical climacteric complaints; and
peri-menopausal if last menses to be within or before 12
months and were not regular. In our study we excluded
peri-menopausal women. A standard questionnaire on
health and menopausal status written in the local lan-
guage was used to identify the pre- and post-menopausal
subjects.
The study was carried out in 4 village communities of
GabindagonjUpazilla (subdistrict) of Gaibandha district,
a poor district of the northern division of Rajshahi, the
poorest region of the country. The respondents were se-
lected randomly after selecting division, district, Upazila
and villages. Women were recruited through local an-
nouncement (loudspeaker) at community level and sur-
veyors visits. The details of the study procedure have
been described before in our previous study [21,22].
In brief, for getting required information, the partici-
pants were interviewed and examined clinically at mo-
bile examination centre and asked to provide a blood
sample. The study was approved by the Ethical Commit-
tee of the Health and Disease Research Center of Rural
Peoples (HDRCRP), Dhaka, Bangladesh. This study con-
formed to the principles outlined in the Helsinki Declara-
tion, and all subjects gave their written informed consent
before inclusion in the study.
Anthropometric measurements
Anthropometric measurements on individuals wearing
light clothing and without shoes were conducted by well-
trained examiners. Height was measured to the nearest
0.1 cm using the portable stadiometer. Weight was mea-
sured in the upright position to the nearest 0.1 kg using a
calibrated balance beam scale. Body mass index (BMI)
was calculated by dividing weight (kg) by height squared
(m2). Waist circumference measurements were taken at
the end of normal expiration to the nearest 0.1 cm, meas-
uring from the narrowest point between the lower borders
of the rib cage and the iliac crest. Blood pressure was mea-
sured twice in the right arm in a sitting position using the
standard mercury manometer and cuff, to the nearest 2
mmHg, with the initial reading taken at least 5 minutes
after the subject was made comfortable, and again after an
interval of 15 minutes. The average systolic and diastolic
blood pressures were then estimated.
Biochemical analysis
Blood for biochemical analysis was obtained from the
participants after 10–12 hours of an overnight fast. The
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ple collection procedure. After venipuncture of blood
the processed serum/plasma were immediately stored at
HDRCRP main or sub-center offices. The serum was im-
mediately separated by centrifugation, and the concen-
tration of triglycerides [lipoprotein lipase method; Wako
Chemicals, Tokyo, Japan], total cholesterol [Cholesterol
E, Wako Pure Chemical Industries, Ltd. Osaka, Japan]
and its fractions high-density lipoprotein (HDL) cho-
lesterol [HDL cholesterol with the Determiner-L kit
(Kyowa Co Ltd, Tokyo, Japan)] were ascertained. Fasting
plasma glucose [glucose with the Hexokinase G-6-PDH
kit (Wako Pure Chemical Industries Ltd, Osaka, Japan)
were also measured. After labeling blood sample vials, a
part of blood were transported to National Centre for
Global Health and Medicine (NCGM), Japan for ad-
vanced biochemical assessment processing.
Definition of metabolic syndrome and risk factors
We defined the metabolic syndrome (MS) using the Na-
tional Cholesterol Education Program Adult Treatment
Panel III (NCEP-ATP III) [23]. As detailed in the NCEP-
ATP III report, participants having three or more of the
five following criteria were defined as having the MS:
high blood pressure (≥130/≥85 mmHg), elevated fasting
blood glucose (≥110 mg/dL or ≥ 6.1 mmol/L), high tri-
glyceride (≥150 mg/dL or ≥1.65 mmol/L), low high-
density lipoprotein (HDL) cholesterol (<50 mg/dL or <1.30
mmol/L), and abdominal obesity, as measured by a waist
circumference of ≥88 cm for women. Participants who
currently reported using antihypertensive or antidiabetic
medication (insulin or oral agents) were counted as having
high blood pressure or elevated fasting blood glucose,
respectively.
Statistical analyses
The clinical and laboratory characteristic of study popula-
tion are presented according to pre- and post-menopausalTable 1 Means of clinical and laboratory characteristics of the
Variable Overall
(n = 1802)
Age, years 39.98 ± 13.97
BMI, kg/m2 21.88 ± 3.97
Waist circumference, cm 76.83 ± 8.32
Systolic blood pressure, mmHg 116.93 ± 21.38
Diastolic blood pressure, mmHg 75.53 ± 10.78
Fasting blood glucose, mmol/L 6.22 ± 2.72
Total cholesterol, mg/dL 181.09 ± 72.32
HDL cholesterol, mg/dL 41.38 ± 30.47
Triglyceride, mg/dL 130.02 ± 109.95
Values are Mean ± SD. BMI: Body mass index, HDL cholesterol: High-density lipoprowomen. The significant differences between pre- and
post-menopausal women were assessed by using the Stu-
dent’s “t” test for continuous variables and chi-square (χ2)
test for categorical variables. Logistic regression analyses
were used to assess the association between menopausal
status and MS and each of its components. Two types of
models were used. The first model was crude model with-
out any adjustment and the second model was adjusted
for age. Statistical significance was set at the conventional
P < 0.05. All analysis were performed using statistical soft-
ware STATA version 12.0 (Lakeway Drive, College Station,
Texas USA).
Result
The clinical and laboratory characteristics of the study
population stratified by menopausal status and MS are
presented in Table 1. A total of 1802 subjects turned out
for data analysis. There were 1094 pre-menopausal and
708 post-menopausal women (ratio 1:1.55); and their ages
ranged from 15–85 (mean 39.98 ± 13.97) years. Figure 1
shows the age and menopausal status distribution of the
study subjects. Most (45.20%) of the study subjects were
in the 45–54 year age group. There were more pre-
menopausal than post-menopausal women across all age
groups. The pre-menopausal women were aged 15–51
years (mean 31.36 ± 9.24) while post-menopausal women
were aged 32–85 years (mean 53.31 ± 8.49) (P < 0.001).
The prevalence of MS and metabolic risk factors are
presented in Table 2. Prevalence of MS was 25.6% in our
study, where 39.3% of post-menopausal women versus
16.8% of pre-menopausal women had MS (P < 0.001).
Prevalence of metabolic risk factors including elevated
fasting blood glucose, high blood pressures, and high tri-
glycerides were significantly higher in post-menopausal
women than pre-menopausal women (P < 0.001). How-
ever, prevalence of low HDL cholesterol was significantly
lower in post-menopausal women than pre-menopausal
women (P = 0.001).subjects
Pre-menopause Post-menopause P value
(n = 1094) (n = 708)
31.36 ± 9.24 53.31 ± 8.49 <0.001
21.87 ± 3.99 21.89 ± 3.94 0.95
76.89 ± 8.54 76.73 ± 7.98 <0.001
110.56 ± 17.95 126 ± 22.51 <0.001
73.00 ± 9.80 79.44 ± 11.07 <0.001
5.77 ± 2.12 6.91 ± 3.35 <0.001
176.15 ± 70.00 188.75 ± 75.18 <0.001
37.34 ± 17.69 45.69 ± 43.20 <0.001
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Figure 1 Age distribution of respondents by menopausal status.
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terval (CI) of MS and each component of MS according
to menopausal status. In unadjusted model the prevalence
of MS was 3.14 times more likely (CI: 2.52-3.92) in
post-menopausal women than pre-menopausal women
(P < 0.001). After adjustment for age the association
was slightly attenuated but remains statistically significant
(OR: 1.78, CI: 1.26-2.51, P = 0.001). Prevalence of elevated
fasting blood glucose, high blood pressures, and high tri-
glycerides were also significantly higher but prevalence of
low HDL cholesterol were significantly lower in post-
menopausal women than pre-menopausal women even
after adjustment for age (P <0.05 for all).
Discussion
In this cross-sectional study of Bangladesh we compare
prevalence of MS and risk variables of MS in pre- andTable 2 Frequency of metabolic risk factors and metabolic sy
Risk factors Overall Pr
n (%) n
BMI > 30 kg/m2 52 (2.9) 34
Elevated waist circumference 152 (8.46) 91
High blood pressures 506 (28.16) 15
Elevated fasting blood glucose 636 (35.39) 28
Low HDL cholesterol 1512 (84.14) 97
High triglyceride 530(29.49) 26
Metabolic Syndrome a 460 (25.60) 18
BMI: Body mass index, HDL cholesterol: High-density lipoprotein cholesterol.
a Metabolic syndrome is defined as presence of at least 3 of the following criteria.
Elevated waist circumference (≥88 cm), high fasting blood glucose (≥110 mg/dL), h
(<50 mg/dL), high blood pressure; systolic blood pressure (SBP ≥ 130 mm Hg) or diapost-menopausal women and also identified how these
variables relate to one another. This is the first report in
Bangladesh investigating the prevalence of MS and each
component of MS risk factors among rural women ac-
cording to their menopausal status.
The prevalence of MS was higher in post-menopausal
(39.3%) women than pre-menopausal (16.8%) women in
our study and this prevalence was more likely in post-
menopausal women even after adjustment for age. Our
findings are consistent with many of previous studies
[11,13-16,24], where post-menopausal women have been
found to be at higher risk of MS than pre-menopausal
women. Ruan et al., found that the prevalence of MS
was 34% among Chinese post-menopausal women [24].
According to a study of Western India the prevalence of
MS was 45% among pre-menopausal women, whereas
it was 55% among post-menopausal women [14]. Inndrome
e-menopause Post-menopause P value
(%) n (%)
(3.11) 18 (2.56) 0.50
(8.32) 61 (8.68) 0.79
9 (14.53) 347 (49.36) <0.001
7 (26.23) 349 (49.64) <0.001
2 (88.85) 540 (76.81) 0.001
2 (23.95) 268 (38.12) <0.001
4 (16.82) 276 (39.26) <0.001
igh triglycerides (≥150 mg/dL), low-high-density lipoprotein (HDL) cholesterol
stolic blood pressure (DBP ≥85 mm Hg).
Table 3 Odds ratio (95% Confidence interval) for
metabolic syndrome and its components by menopausal
status
Risk factors Pre-menopause Post-menopause P valuea
Elevated waist
circumference
Unadjusted 1.00 1.04 (0.74-1.46) 0.829
Age-adjusted 1.00 0.66 (0.39-1.12) 0.124
High blood pressures
Unadjusted 1.00 5.65 (4.50-7.07) <0.001
Age-adjusted 1.00 1.72 (1.22-2.43) 0.002
Elevated fasting
blood glucose
Unadjusted 1.00 2.84 (2.32-3.47) <0.001
Age-adjusted 1.00 1.63 (1.19-2.23) 0.002
Low HDL cholesterol
Unadjusted 1.00 0.41 (0.31-0.53) <0.001
Age-adjusted 1.00 0.44 (0.29-0.67) <0.001
High triglyceride
Unadjusted 1.00 1.96 (1.59-2.41) <0.001
Age-adjusted 1.00 2.27 (1.62-3.17) <0.001
Metabolic syndrome b
Unadjusted 1.00 3.14 (2.52-3.92) <0.001
Age-adjusted 1.00 1.78 (1.26-2.51) 0.001
HDL cholesterol: High-density lipoprotein cholesterol.
a Based on logistic regression analysis.
b Metabolic syndrome is defined as presence of at least 3 of the
following criteria.
Elevated waist circumference (≥88 cm), high fasting blood glucose (≥110 mg/dL),
high triglycerides (≥150 mg/dL), low-high-density lipoprotein (HDL) cholesterol
(<50 mg/dL), high blood pressure; systolic blood pressure (SBP ≥ 130 mm Hg) or
diastolic blood pressure (DBP ≥85 mm Hg).
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pre-menopausal as compared to 32.2% in the post-
menopausal group was reported [25]. Arguing meno-
pause as an independent predictor of MS, Eshtiaghi
et al., showed a prevalence of 53.5% MS in post-
menopausal Iranian women, on the other hand it was
only 18% in pre-menopausal women [13]. Taken to-
gether, post-menopausal women are more prone to have
MS than pre-menopausal women in Bangladesh.
The transition from pre- to post-menopause may be
associated with each feature of the MS. In our study
metabolic risk factors including high blood pressures,
high triglyceride, and elevated fasting blood glucose are
significantly higher among post-menopausal women than
pre-menopausal women. However, prevalence of low HDL
cholesterol is significantly lower in post-menopausal wo-
men than pre-menopausal women. In agreement with the
results of our study, many previous studies have reported
higher concentrations of hypertension [11,15,26], hy-
percholesterolemia [15], hypertriglyceridemia [5], and
elevated fasting blood glucose [11,15] among post-menopausal women than pre-menopausal women. The
decreased prevalence of low HDL cholesterol among post-
menopausal women than pre-menopausal women is
supported by a previous study [27]. Nonetheless, lower
prevalence of low HDL cholesterol among post-meno-
pausal women than pre-menopausal women is at variance
with other studies [11,15]. Further research is required to
elucidate the inconsistencies among studies.
The emergence of metabolic risk factors in post-
menopausal phase may be a direct result of ovarian
failure with estrogen deficiency. Decrease in estrogen
production is thought to be responsible for substantial
proportion of increased cardio-metabolic risk factors in
post-menopausal women. Changes in metabolic risk fac-
tors during pre- and post-menopause may be due to a
combination of factors of the aging process. Although
previous studies showed age as the predominant variable
associated with increased prevalence of MS, but higher
prevalence of MS among women >50 years compared
with men of the same age has been reported [28]. In our
study the association between menopausal status and
each component of metabolic MS was not significantly
changed even after adjustment for age, which implies
that post-menopausal women were indeed at higher risk
of having MS and cardiovascular diseases.
In our study we found no significant difference in
obesity component including BMI and waist circumfe-
rence. Our findings are consistent with two previous
studies of India [14] and Iran [16]. In addition, in a
Framingham study [29] no significant difference was
detected between BMI of pre- and post-menopausal
women. However, significant differences in central body
fat and BMI among pre- and post-menopausal women
have been found in many other studies [11,15]. During
menopause the pattern of hormone secretion changes
and gradually causes fat accumulation in visceral tissues
of abdomen and as a result, central obesity. However,
the literature to date is not clear as to menopause itself
is directly associated with obesity. Results of our study
demonstrated that although there was no significant dif-
ference in abdominal obesity, the risk of MS was more
prevalent among post-menopausal women due to sig-
nificant difference among other component of MS. Dif-
ferences in socio-environmental and genetic factors,
lifestyles, type of menopause (natural/surgical) could be
some of the reasons for this variability.
To the best of our knowledge, our study is the first
to demonstrate the prevalence of MS and its compo-
nents among pre- and post-menopausal women in a
low-income country like Bangladesh. One of the major
strengths of the present study is that it is based on the
largest community-based and comprehensive MS survey.
However, our study has several limitations that need
to be mentioned. First, an association derived from a
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ality. Second, menopausal status was self-reported and
could have recall bias. Third, our study may have selec-
tion bias during cases recruitment due to selection of
rural women from lower socioeconomic class and may
not be generalized to the whole Bangladeshi women.
Conclusions
In conclusion, the results of our study suggest that the
prevalence of MS in post-menopausal women was signi-
ficantly higher than pre-menopausal women. Low HDL
cholesterol, elevated fasting blood glucose, and high
blood pressures were the most frequent features in com-
parison to the others. Prevention through changes in
lifestyle, or early detection and treatment of elevated
fasting blood glucose, hypertension, and hyperlipidemia
are necessary for prevention of many chronic diseases in
Bangladeshi women reaching after menopausal status.
Health professionals should consider the post-meno-
pausal women as a major target group for prevention of
MS, which is an underlying condition of many non-
communicable diseases.
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